liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
High-energy feedback microwave thermotherapy and intraprostatic injections of mepivacaine and adrenaline: an evaluation of calculated cell kill accuracy and responder rate
University of Gothenburg, Sweden Kalmar County Hospital, Sweden .
Linköping University, Department of Medical and Health Sciences, Division of Cardiovascular Medicine. Linköping University, Faculty of Health Sciences.
University of Gothenburg, Sweden .
University of Gothenburg, Sweden .
2014 (English)In: Scandinavian journal of urology, ISSN 2168-1805, E-ISSN 2168-1813, Vol. 48, no 4, 374-378 p.Article in journal (Refereed) Published
Abstract [en]

Objective. The aim of this study was to evaluate cell kill accuracy and responder rate when using injections of intraprostatic mepivacaine and adrenaline (MA) before high-energy microwave thermotherapy (HE-TUMT). Material and methods. This retrospective evaluation encompassed 283 treatments in men with lower urinary tract symptoms or urinary retention due to benign prostatic hyperplasia. They were treated consecutively during 2003-2008 using HE-TUMT with a feedback technique. Immediately before treatment, MA was administered into the prostate via a Schelin Catheter (R). Clinical outcome was evaluated 3 months after treatment using a validated symptom score, transrectal ultrasound, peak urinary flow and postvoid residual. Results. Systematic underestimation of the resulting coagulation necrosis was a consistent finding when using MA, a calculated cell kill of 21% yielding a volume reduction of 26% for prostate volumes less than 100 ml and 31% for prostate volumes greater than or equal to 100 ml. Mean prostate volume was 74 ml and mean treatment time was 13 min. Less than 1% of the patients needed analgesics or sedatives on demand. Analysis of the data showed an estimated clinical responder rate of approximately 87%. Conclusions. The resulting prostate volume reduction corresponds to the earlier empirically recommended 30% cell kill for CoreTherm (R) without MA. The treatment concept combining CoreTherm with intraprostatic injections of MA corresponds to the clinical outcome of thermotherapy without MA, with the benefits of reduced pain, shortened treatment tithe and decreased energy consumption.

Place, publisher, year, edition, pages
Informa Healthcare , 2014. Vol. 48, no 4, 374-378 p.
Keyword [en]
Adrenaline; benign prostatic hyperplasia; intraprostatic injection; mepivacaine; microwave thermotherapy
National Category
Clinical Medicine
URN: urn:nbn:se:liu:diva-110287DOI: 10.3109/21681805.2013.879921ISI: 000340072700008PubMedID: 24521182OAI: diva2:744027

Funding Agencies|Sahlgrenska University Hospital [ALF 7582]

Available from: 2014-09-05 Created: 2014-09-05 Last updated: 2014-09-05

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Brudin, Lars
By organisation
Division of Cardiovascular MedicineFaculty of Health Sciences
In the same journal
Scandinavian journal of urology
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 25 hits
ReferencesLink to record
Permanent link

Direct link